E-LIB Suche - Ergebnisse für: Charokopou, M.

1

A novel economic framework to assess the cost-effectiveness..:

Söreskog, E. ; Borgström, F. ; Lindberg, I....
Osteoporosis International. 32 (2021) 7 - p. 1301-1311 , 2021

Link: https://doi.org/10.1007/..

2

Cost effectiveness of romosozumab versus teriparatide for s..:

Hagino, H. ; Tanaka, K. ; Silverman, S....
Osteoporosis International. 32 (2021) 10 - p. 2011-2021 , 2021

Link: https://doi.org/10.1007/..

3

PNS22 Network Meta-Analysis: A Comparison of Bayesian and F..:

Harvey, R. ; Charokopou, M. ; Arteaga Duarte, C..
Value in Health. 23 (2020) - p. S647 , 2020

Link: https://doi.org/10.1016/..

4

PNS28 ADVANCING VALUE ASSESSMENTS: HOW CAN A PARADIGM OF VA..:

Willems, D. ; Pinterova, M. ; Jackson, D....
Value in Health. 22 (2019) - p. S767 , 2019

Link: https://doi.org/10.1016/..

5

PCP14 - VALUE FRAMEWORKS AND PRICING SETTING; CAN THEY CO-E..:

Charokopou, M. ; Harris, K. ; Pinterova, M...
Value in Health. 21 (2018) - p. S84 , 2018

Link: https://doi.org/10.1016/..

6

PMS43 - AN ECONOMIC VALUE FRAMEWORK TO ASSESS THE COST EFFE..:

Jonsson, E. ; Borgström, F. ; Ström, O....
Value in Health. 21 (2018) - p. S295 , 2018

Link: https://doi.org/10.1016/..

7

Risk of Major Osteoporotic Fracture (Hip, Vertebral, Radius..:

Jonsson, E ; Ström, O ; Spångéus, A...
Value in Health. 20 (2017) 9 - p. A528 , 2017

Link: https://doi.org/10.1016/..

8

Lacosamide As First Line Treatment Option In Focal Epilepsy..:

Geitona, M ; Stamuli, E ; Giannakodimos, S...
Value in Health. 20 (2017) 9 - p. A724 , 2017

Link: https://doi.org/10.1016/..

9

Cost-Effectiveness of Brivaracetam As Adjunctive Therapy fo..:

Väätäinen, S ; Soini, E ; Peltola, J...
Value in Health. 20 (2017) 9 - p. A722 , 2017

Link: https://doi.org/10.1016/..

10

Relative Efficacy and Tolerability of Lacosamide Versus Lev..:

Kroep, S ; Bouwmeester, W ; Zhang, Y...
Value in Health. 20 (2017) 9 - p. A718 , 2017

Link: https://doi.org/10.1016/..

11

Do Accepted Techniques for Indirect Comparative Effectivene..:

Borghs, S ; Harvey, RC ; Srivastava, K..
Value in Health. 19 (2016) 3 - p. A71 , 2016

Link: https://doi.org/10.1016/..

12

Applying The Accepted Techniques of Indirect Treatment Comp..:

Charokopou, M ; Harvey, R ; Sristava, K..
Value in Health. 19 (2016) 7 - p. A359 , 2016

Link: https://doi.org/10.1016/..

13

Cost-Effectiveness of Brivaracetam Versus Other Antiepilept..:

Charokopou, M ; Sander, J ; Saha, R...
Value in Health. 19 (2016) 7 - p. A365 , 2016

Link: https://doi.org/10.1016/..

14

A Systematic Literature Review And Network Meta-Analysis of..:

van Nooten, FE ; Charokopou, M ; Poole, C.
Value in Health. 18 (2015) 7 - p. A659 , 2015

Link: https://doi.org/10.1016/..

15

Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors..:

Charokopou, M. ; McEwan, P. ; Lister, S....
BMC Health Services Research. 15 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..